Antipodes, a leading Sydney-based investment manager specialising in global equities, is pleased to announce the appointment of Vihari Ross as a Portfolio Manager, effective 27 March 2023.
Ms Ross joins after a 15-year career at Magellan Asset Management where she was most recently Head of Research, responsible for the management of a 30-person global research team.
Before joining Magellan, Ms Ross worked at Ausbil Dexia from 2003 to 2007 where she covered the Financial and Consumer sectors. Prior to Ausbil, she commenced her investing career at Commonwealth Investment Management in a strategy and research role from 2000 to 2002.
Jacob Mitchell, Antipodes’ Chief Investment Officer, commented on the appointment.
“Vihari is a very knowledgeable investor who has covered global equities over many years and through various market cycles. Her appointment as a Portfolio Manager at Antipodes will further bolster our experienced portfolio management team at a time when active management is arguably more important than ever”.
Ms Ross said Antipodes’ investment approach and respected team attracted her to the role.
“I have always had great respect for the client-centric Antipodes team, and the firm’s unique pragmatic value investment style. I’m thrilled to be joining such a dynamic and forward-thinking firm.”
Ms Ross holds a Bachelor of Commerce (Actuarial Studies and Finance) and a Master of Commerce (Finance) from the University of New South Wales and is an Associate of the Institute of Actuaries.
Her appointment follows the recent expansion of Antipodes’ investment offerings.
In January, the firm established the Antipodes Climate Delta Fund, led by portfolio manager Max Shramchenko with Graham Hay as Co-PM. The strategy aims to invest in attractively valued global companies exposed to climate impact mitigation and the transition to net zero.
Antipodes has also recently launched the Antipodes Global Opportunities Fund – a small and mid-cap global equities strategy managed by James Rodda as Lead PM and Nick Cameron as Co-PM.
Over the past year (to end February 2023), the Antipodes Global Fund – Long outperformed its benchmark by 6.9% (delivering 5.6% vs -1.3% for the MSCI All Country World Net Index). Since its inception in July 2015, the value-style fund has delivered 9.7% per annum vs 9.1% for the benchmark (to end February 2023).